Back

Inhibition of Candida albicans virulence factor by cyclic dipeptides derived from Aeromonas veronii V03

Sekar, J.; Parasuraman, G.; Dharumadurai, D.; Dileep Kumar, B. S.; Natesan, S.

2024-10-25 microbiology
10.1101/2024.10.24.619162 bioRxiv
Show abstract

Candida albicans is the most common human fungal pathogen with high mortality rates and limited antifungal treatments. Inhibition of C. albicans pathogenesis by targeting virulence factors provides a promising strategy for the development of novel antifungal drugs and overcoming drug resistance. In this study, four structurally different cyclic dipeptides (or diketopiperazine(DKP) were isolated and identified as cyclo(L-Pro-L-Leu), cyclo(L-Pro-L-Val), cyclo(D-Pro-L-Phe), and cyclo(L-Pro-D-Tyr) from Aeromonas veronii V03 and their antimicrobial potentials were evaluated. Results revealed that identified DKPs exhibited antibacterial activity against bacterial pathogens, such as Staphylococcus aureus, Proteus mirabilis, Pseudomonas aeruginosa, and Aeromonas hydrophila. Importantly, cyclo(D-Pro-L-Phe) lacking hydroxyl groups showed potent inhibitory effects against C. albicans and non-albicans species with low concentrations. Moreover, identified DKPs inhibited the virulence traits of C. albicans, including yeast-to-hyphae transition, secreted hydrolases (aspartic proteases and phospholipase) and biofilm formation in a dose-dependent manner. Collectively, our findings suggest that cyclic dipeptides from DKPs derived from A. veronii V03 could potentially be developed as antivirulence agents against C. albicans infection.

Matching journals

The top 8 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.